Market revenue in 2023 | USD 43.5 million |
Market revenue in 2030 | USD 89.8 million |
Growth rate | 10.9% (CAGR from 2023 to 2030) |
Largest segment | Tavr (transcatheter aortic valve replacement) |
Fastest growing segment | LAAC (Left Atrial Appendage Closure) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | SAVR (Surgical Aortic Valve Replacement), TAVR (Transcatheter Aortic Valve Replacement), Mitral Repair (Annuloplasty), LAAC (Left Atrial Appendage Closure) |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Edwards Lifesciences Corp, Abbott Laboratories, St. Jude Medical, LivaNova PLC, Stryker Corp, Lepu Medical, Biomerics, CardioKinetix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to structural heart devices market will help companies and investors design strategic landscapes.
Tavr (transcatheter aortic valve replacement) was the largest segment with a revenue share of 51.95% in 2023. Horizon Databook has segmented the South Africa structural heart devices market based on savr (surgical aortic valve replacement), tavr (transcatheter aortic valve replacement), mitral repair (annuloplasty), laac (left atrial appendage closure) covering the revenue growth of each sub-segment from 2018 to 2030.
The South African market for structural heart devices is on the cusp of a substantial expansion, propelled by a multitude of factors. These include the escalating incidence of SHD, the advancement of medical technology, and the growing preference for minimally invasive treatments.
The enhancement of South Africa's healthcare infrastructure, with an emphasis on early detection and treatment of structural heart conditions, has paved the way for the adoption of sophisticated cardiovascular care technologies.
This infrastructure improvement, coupled with favorable reimbursement scenarios for structural heart procedures and devices, as well as regulatory approvals for innovative structural heart devices, has significantly bolstered the market's growth trajectory. TAVI stands out as a pivotal development within the South African structural heart devices market.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa structural heart devices market , including forecasts for subscribers. This country databook contains high-level insights into South Africa structural heart devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account